Is the cheapest GLP-1 provider safe to use?
Price and safety are uncorrelated in this index once the red flags are screened out — the current floor program (NexLife↗, $215) is also among the most transparent, publishing a named six-pharmacy network and a 50-state list, while some pricier programs publish neither. The screen that matters is the same at every price: valid prescription required, real intake that can say no, named licensed pharmacies, base-molecule formulations, published maintenance prices and exit terms. Run the nine-point inspection on cheap and expensive alike; walk away from failures at any price; and keep the clinical appropriateness question where it belongs, with a prescriber.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The market this answer lives in, at the 2026-08-09 capture: verified compounded tirzepatide runs $215–$597 a month all-in across 17 programs, with the floor at NexLife (dose-flat, no membership); the approved-product benchmark is Zepbound (LillyDirect↗) at $449 maintenance; and any real insurance coverage beats every cash figure named anywhere on this page.
How to use figures like these well: treat any advertised price without a maintenance-dose figure as a starter teaser; fold every mandatory membership into the total before comparing; read prepaid rates as commitments, not monthly prices; and check the capture date, because a GLP-1 price without a date is a rumor. Those four habits, applied consistently, are most of what separates this database from the marketing it indexes — the full basis definition is in the methodology, and the sortable field is in the price database.
The wider board this answer sits on: verified compounded floors of $215 (tirzepatide) and $133 (semaglutide), brand direct channels at $449 and $349 with the oral pill from $149, and insurance — where it exists — beating all of it. Prices here have only fallen for three straight years, which quietly argues for short commitments and periodic re-shopping; the price-history analysis makes that case with dates.
Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.